Submitted by Anonymous (not verified) on 30 November 2023 - 13:09
Human medicines European public assessment report (EPAR): Soliris, eculizumab, Hemoglobinuria, Paroxysmal, Date of authorisation: 20/06/2007, Revision: 36, Status: Authorised
Source: